Antireflux surgery, barrett esophagus, and adenocarcinoma: There is still room for doubt

Annals of Surgery

Volumn 246, Issue 1, 2007, Pages 22-23

  Jamieson, Glyn G ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER PREVENTION; CARCINOGENESIS; EDITORIAL; ESOPHAGEAL ADENOCARCINOMA; HUMAN; INTERMETHOD COMPARISON; PRIORITY JOURNAL;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL NEOPLASMS; HUMANS; PRECANCEROUS CONDITIONS; TREATMENT OUTCOME;

EID: 34347352175     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/SLA.0b013e318070d3b7     Document Type: Editorial

References (13)

1. Ye W, Chow W-H, Lagergren J, et al. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastresophageal reflux disease and after antireflux surgery. Gastroenterology. 2001;121:1286-1293.
2. Hofstetter WL, Peters JH, DeMeester TR, et al. Long-term outcome of antireflux surgery in patients with Barrett's esophagus. Ann Surg. 2001;234:532-539.
3. Williamson WA, Ellis FH Jr, Gibb SP, et al. Effect of antireflux operation on Barrett's mucosa. Ann Thoracic Surg. 1990;49:537-541.
4. O'Riordan JM, Byrne PJ, Narayanasamy R, et al. Long-term clinical and pathologic response of Barrett's esophagus after antireflux surgery. Am J Surg. 2004;188:27-33.
5. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340:825-831.
6. Oberg S, DeMeester TR, Peters JH, et al. The extent of Barrett's esophagus depends on the status of the lower esophageal sphincter and the degree of esophageal acid exposure. J Thorac Cardiovascular Surg. 1999;117:572-580.
7. Csendes A, Maluenda F, Braghetto I, et al. Location of the lower esophageal sphincter and the squamous columnar mucosal junction in 109 healthy controls and 778 patients with different degrees of endoscopic esophagitis. Gut. 1993;34:21-27.
8. Dent J, El-Serag HB, Wallander M-A, et al. Epidemiology of gastrooesophageal reflux disease: a systematic review. Gut. 2005;54:710-717.
9. Ronkainen J, Aro P, Storskrubb T, et al. Prevalence of Barrett's esophagus in general population: an endoscopic study. Gastroenterology. 2005;129:1825-1831.
10. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998;83:2049-2053.
11. Sabel MS, Pastore K, Toon H, et al. Adenocarcinoma of the esophagus with and without Barrett's mucosa. Arch Surg. 2000;135:831-835.
12. Zhang X, Watson DI, Jamieson GG, et al. Outcome of oesophagectomy for adenocarcinoma of the oesophagus and oesophagogastric junction. Aust NZ J Surg. 2005;75:513-519.
13. Rudolph RE, Vaughan TL, Storer BE, et al. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus. Ann Intern Med. 2000;132:612-620.